alexa
Reach Us +447482876457
A Polycaprolactone - Gelatinenanofibre Matrix As A Combined Growth And Delivery System For Endothelial Progenitor Cells (EPCs) In Treatment Of Diabetic Wounds | 5320
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

A polycaprolactone - gelatinenanofibre matrix as a combined growth and delivery system for endothelial progenitor cells (EPCs) in treatment of diabetic wounds

International Conference on Tissue Science & Engineering

Meghana Kanitkar and Vaijayanti Kale

Posters: J Tissue Sci Eng

DOI: 10.4172/2157-7552.S1.007

Abstract
P rolonged diabetes mellitus (DM) induced endothelial progenitor cell (EPC) dysfunction causes impaired wound healing which may be rescued by delivery of large numbers of ?normal? EPCs to wound sites. The challenge herein isculturing the number of EPCs required and in achieving sustained delivery onto wound sites for effective participation in the diabetic wound healing process. Most known scaffolds allow adhesion, but not growth or proliferation of EPCs and may / may not permit delivery onto wound sites. Clearly, a matrix that can perform a multitude of functions is the need of the day. To remedy these lacunae, we standardized direct seeding and attachment of murine bone marrow MNCs onto a uniformly smooth polycaprolactone : gelatine (PCG) nano-fibre matrix, followed by 14 day culture. Cellularsaays such as CAA, CFC, proliferation and viability assays revealed that seeding of BM-MNCs directly onto the PCG matrix allowsenhanced 4.42 fold attachment of BM- MNCs, andpromoted growth, colony formation (1.33 fold) as well as proliferation (1.25 fold)as compared to controls, without compromising viability of EPCs. In vitro, the PCG-matrix allows chemotactic migration of cells while facilitating sustained delivery of EPCs onto diabetic wounds, resulting in a pathologically significant, scar-freehealing of diabetic wounds. Our data, thus, highlight the novel therapeutic potential of the ?PCG-embedded EPCs? - as a combined ?growth and delivery system?- functioning both as a ?substrate? for direct seeding, and growth of EPCs and as a ?scaffold? for direct application onto diabetic wounds.
Biography
Meghana has completed her Ph.D in 2007 and is currently pursuing her postdoctoral research in the National Centre for Cell Science, Pune, India. Her research interests are EPC dysfunction and rescue for improved wound healing in diabetes mellitus
Leave Your Message 24x7
Top